{
  "nctId": "NCT06856668",
  "briefTitle": "A Megastudy of Single-Session Interventions for Depression",
  "officialTitle": "A Megastudy of Single-Session Interventions to Challenge Depression in American Adults",
  "protocolDocument": {
    "nctId": "NCT06856668",
    "filename": "Prot_SAP_ICF_001.pdf",
    "label": "Study Protocol, Statistical Analysis Plan, and Informed Consent Form",
    "date": "2025-03-08",
    "uploadDate": "2025-03-08T10:40",
    "size": 162531,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT06856668/document/Prot_SAP_ICF_001.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": true
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "QUADRUPLE",
  "enrollmentInfo": {
    "enrollmentCount": 7505,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2025-03-11",
    "completionDate": "2025-06-24",
    "primaryCompletionDate": "2025-06-24",
    "firstSubmitDate": "2025-01-27",
    "firstPostDate": "2025-03-04"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion criteria:\n\n* At least 18 years old\n* Able to read and write fluently in English\n* Have enough access to the internet to complete two sessions over four weeks\n* Score at least 10 on the PHQ-9 screen (suggesting moderate depression; Kroenke et al., 2001)\n* Pass the bot check during the screening survey\n\nAll participants who are randomized to an experimental condition (and therefore completed all baseline measures) will be included in analyses, except for participants who indicate at the end of either the baseline or week 4 session that they did not participate in the study seriously. Researchers will only keep data from the first survey session a participant begins.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Change in Patient Health Questionnaire-9 at week 4 (PHQ-9; Kroenke et al., 2001)",
        "description": "The Patient Health Questionnaire-9 is a validated and self-administered measure to assess depression symptom severity in the general population. Participants are asked to rate how often they are bothered by 9 items (e.g., Poor appetite or overeating) on a scale of 0 (Not at all) to 3 (Nearly every day). Total score can range from 0 to 27, with higher scores indicating higher symptom severity.",
        "timeFrame": "Baseline to week 4"
      }
    ],
    "secondary": [
      {
        "measure": "Change in Beck Hopelessness Scale at immediate post-intervention (BHS-4; Perczel Forintos et al., 2013)",
        "description": "Beck Hopelessness Scale-4 is the 4-item version of the 20-item Beck Hopelessness scale (Beck et al. 1974). Participants will be asked to rate 4 items assessing different aspects of hopelessness (e.g., My future seems dark to me) on a scale of 0 (Absolutely disagree) to 3 (Absolutely agree). Total score can range between 0 to 12 with higher scores indicating higher hopelessness.",
        "timeFrame": "Baseline to immediate post-intervention"
      },
      {
        "measure": "Change in Beck Hopelessness Scale at week 4 (BHS-4; Perczel Forintos et al., 2013)",
        "description": "Beck Hopelessness Scale-4 is the 4-item version of the 20-item Beck Hopelessness scale (Beck et al. 1974). Participants will be asked to rate 4 items assessing different aspects of hopelessness (e.g., My future seems dark to me) on a scale of 0 (Absolutely disagree) to 3 (Absolutely agree). Total score can range between 0 to 12 with higher scores indicating higher hopelessness.",
        "timeFrame": "Baseline to week 4"
      },
      {
        "measure": "Change in Pathways Subscale of the State Hope Scale at immediate post-intervention (Snyder et al., 1996)",
        "description": "The \"pathways\" subscale reflects perceived success in meeting one's goals (eg, \"At this time, I am meeting the goals I have set for myself\"). Immediately pre- and post-intervention, participants rate each of 3 statements to reflect how they felt about themselves right now on an 8-point Likert scale.",
        "timeFrame": "Baseline to immediate post-intervention"
      },
      {
        "measure": "Change in Pathways Subscale of the State Hope Scale at week 4 (Snyder et al., 1996)",
        "description": "The \"pathways\" subscale reflects perceived success in meeting one's goals (eg, \"At this time, I am meeting the goals I have set for myself\"). Immediately pre- and post-intervention, participants rate each of 3 statements to reflect how they felt about themselves right now on an 8-point Likert scale.",
        "timeFrame": "Baseline to week 4"
      },
      {
        "measure": "Change in Readiness for Change at immediate post-intervention",
        "description": "To evaluate readiness for change at pre-test, post-test, and follow-up, participants will be asked two questions regarding making changes to reduce their feelings of depression: 1. \"How important is making changes toward overcoming depression to you right now?\" (1-4, Not at all- Extremely important) and 2. \"How confident are you about making changes toward overcoming depression?\" (1-4, Not at all- Extremely confident).",
        "timeFrame": "Baseline to immediate post-intervention"
      },
      {
        "measure": "Change in Readiness for Change at week 4",
        "description": "To evaluate readiness for change at pre-test, post-test, and follow-up, participants will be asked two questions regarding making changes to reduce their feelings of depression: 1. \"How important is making changes toward overcoming depression to you right now?\" (1-4, Not at all- Extremely important) and 2. \"How confident are you about making changes toward overcoming depression?\" (1-4, Not at all- Extremely confident).",
        "timeFrame": "Baseline to week 4"
      },
      {
        "measure": "Change in Depression Expectancies for Change at immediate post-intervention (Eddington et al., 2014)",
        "description": "To evaluate how much people expect to be able to change their symptoms of depression, participants will respond to the three items with the highest item-total correlation from the Depression Expectancies for Change scale (Eddington et al., 2014). These are rated on a 5-point likert scale from 1 (strongly disagree) to 5 (strongly agree). Items 1 and 2 are reverse-coded.",
        "timeFrame": "Baseline to immediate post-intervention"
      },
      {
        "measure": "Change in Depression Expectancies for Change at week 4 (Eddington et al., 2014)",
        "description": "To evaluate how much people expect to be able to change their symptoms of depression, participants will be asked to respond to three items with the highest item-total correlation from the Depression Expectancies for Change scale (Eddington et al., 2014). These are rated on a 5-point likert scale from 1 (strongly disagree) to 5 (strongly agree). Items 1 and 2 are reverse-coded.",
        "timeFrame": "Baseline to week 4"
      },
      {
        "measure": "Change in Frequency of Actions and Thoughts Scale at immediate post-intervention (FATS; Terides et al., 2016).",
        "description": "A 12-item measure of adaptive thoughts and behaviors, improvement in which might be a target of psychotherapy. Range 0-48 with higher scores indicating greater frequency of adaptive thoughts and behaviors.",
        "timeFrame": "Baseline to immediate post-intervention"
      },
      {
        "measure": "Change in Frequency of Actions and Thoughts Scale at week 4 (FATS; Terides et al., 2016).",
        "description": "A 12-item measure of adaptive thoughts and behaviors, improvement in which might be a target of psychotherapy. Range 0-48 with higher scores indicating greater frequency of adaptive thoughts and behaviors.",
        "timeFrame": "Baseline to week 4"
      },
      {
        "measure": "Credibility and Expectancy Questionnaire at immediate post-intervention (CEQ; Devilly & Borkovec; 2000)",
        "description": "A 6-item measure of user-perceived intervention appeal and efficacy. Range 6-54 with higher scores indicating higher user-perceived intervention appeal and efficacy.",
        "timeFrame": "immediate post-intervention"
      },
      {
        "measure": "Insight Experience at immediate post-intervention",
        "description": "Participants will be asked two questions about users' insight experiences, with the following text:\n\nThe next question will ask if you experienced an \"Aha! Moment\".\n\nYou can think of this experience as a miniature 'Eureka moment'. You might even feel an internal sense of \"Aha!,\" or you might think to yourself, \"of course!,\" \"that was so obvious\". Not experiencing an Aha! moment might feel like nothing much at all.\n\n1. Did something in the program make you experience an Aha! Moment? (No 0 / Yes 1)\n2. How significant did you feel this Aha! Moment was? In other words, how much do you feel it will have a lasting impact on you? 1 (not at all significant) - 5 (very significant)",
        "timeFrame": "immediate post-intervention"
      },
      {
        "measure": "Insight Experience at week four",
        "description": "Participants will be asked three questions about whether they had an insight experience during the SSI, with the following text:\n\nThe next question will ask if you experienced an \"Aha! Moment\".\n\nYou can think of this experience as a miniature 'Eureka moment'. You might even feel an internal sense of \"Aha!,\" or you might think to yourself, \"of course!,\" \"that was so obvious\". Not experiencing an Aha! moment might feel like nothing much at all.\n\n1. Did something in the program make you experience an Aha! Moment \\*that you still remember today\\*? (No 0 / Yes 1)\n2. How significant did you feel this Aha! Moment was? In other words, how much do you feel it will have a lasting impact on you? 1 (not at all significant) - 5 (very significant)\n3. How much has the Aha! Moment you experienced changed the way that you think or act? 1 (not at all) - 5 (a great deal)",
        "timeFrame": "week 4"
      },
      {
        "measure": "Star rating at immediate post-intervention",
        "description": "Participants rate the overall quality of the program they completed from 1-5 stars, with 5 being the best. (5 stars to fill in, discrete 1-5)",
        "timeFrame": "immediate post-intervention"
      },
      {
        "measure": "Star rating at week 4",
        "description": "Participants rate the overall quality of the program they completed from 1-5 stars, with 5 being the best. (5 stars to fill in, discrete 1-5)",
        "timeFrame": "week 4"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 0,
      "exclusionCount": 0,
      "totalCount": 0
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 15,
      "otherCount": 0,
      "totalCount": 16
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 100,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:29:18.206Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}